MedPath

Coronal Mode Ultrasound Guided Hemodialysis Cannulation: Comparison With Standard Cannulation Technique

Not Applicable
Completed
Conditions
Arteriovenous Fistula, Cannulation
Registration Number
NCT02814721
Lead Sponsor
Henry Ford Health System
Brief Summary

Infiltrations from cannulation difficulties result in significant morbidity including loss of vascular access (VA) loss in hemodialysis (HD). Cannulation is reliant on personnel skill and VA characteristics. Surface marking of VA lacks real-time information and traditional ultrasound (US) devices are large, expensive and require skilled operator expertise. Sonic Window© (Analogic Ultrasound, Peabody, MA) is a coronal mode ultrasound device (CMUD) approved for VA cannulation. Study is a single center randomized, prospective pilot study comparing handheld US-guided cannulation of new arteriovenous fistula (AVF) to standard cannulation practices.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
10
Inclusion Criteria
  • End-stage renal disease with new arteriovenous fistula being started for cannulation
Exclusion Criteria
  • End-stage renal disease with grafts

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Infiltration Due to Dialysis Access Cannulation3 weeks from use of fistula

Infiltration is the extravasation of blood from fistula due to problems with needle insertion into fistula for dialysis.

Secondary Outcome Measures
NameTimeMethod
Patient Pain Scale3 weeks from use of fistula

Measured using a scale of 1-10 with 10 being the most severe pain

Trial Locations

Locations (1)

GHS West pavilion dialysis center

🇺🇸

Detroit, Michigan, United States

GHS West pavilion dialysis center
🇺🇸Detroit, Michigan, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.